BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership56,879 shares
Latest Disclosed Value $ 16,859,037
Dimensional Fund Advisors Lp reports 15.93% increase in ownership of ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 56,879 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $16,891,357 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 49,064 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 15.93% during the quarter. The current value of the position is $15,869,241 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 56,879 7,815 15.93 16,859 13.09 0.0008
2026-02-12 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 49,064 9,272 23.30 14,908 10.14 0.0031
2025-11-12 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 39,792 9,277 30.40 13,535 83.24 0.0029
2025-08-12 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 30,515 8,521 38.74 7,387 23.70 0.0017
2025-05-13 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 21,994 538 2.51 5,971 50.74 0.0015
2025-02-13 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 21,456 441 2.10 3,962 -15.78 0.0010
2024-11-07 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 21,015 9,516 82.76 4,704 185.20 0.0011
2024-08-09 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 11,499 6,246 118.90 1,649 100.85 0.0004
2024-05-10 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 5,253 -6,036 -53.47 822 -59.66 0.0002
2024-02-07 2023-12-31 13F BEIGENE SPONSORED ADR 07725L102 11,289 -195 -1.70 2,035 -1.79 0.0006
2023-11-09 2023-09-30 13F BEIGENE SPONSORED ADR 07725L102 11,484 -710 -5.82 2,073 -4.74 0.0007
2023-08-09 2023-06-30 13F BEIGENE SPONSORED ADR 07725L102 12,194 -275 -2.21 2,176 -19.14 0.0007
2023-05-12 2023-03-31 13F BEIGENE SPONSORED ADR 07725L102 12,469 -484 -3.74 2,691 134,400.00 0.0009
2023-02-09 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 12,953 -1,362 -9.51 3 -99.90 0.0008
2022-11-10 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 14,315 -928 -6.09 1,933 -21.42 0.0007
2022-08-12 2022-06-30 13F BEIGENE SPONSORED ADR 07725L102 15,243 -125 -0.81 2,460 -16.18 0.0009
2022-05-13 2022-03-31 13F BEIGENE ADR 07725L102 15,368 2,047 15.37 2,935 -18.77 0.0009
2022-02-09 2021-12-31 13F BEIGENE ADR 07725L102 13,321 -202 -1.49 3,613 -26.39 0.0011
2021-11-12 2021-09-30 13F BEIGENE ADR 07725L102 13,523 -6,919 -33.85 4,908 -30.43 0.0016
2021-08-12 2021-06-30 13F BEIGENE ADR 07725L102 20,442 -3,207 -13.56 7,055 -13.49 0.0022
2021-05-14 2021-03-31 13F BEIGENE ADR 07725L102 23,649 412 1.77 8,155 36.05 0.0027
2021-03-08 2020-12-31 13F/A-2 BEIGENE ADR 07725L102 23,237 57 0.25 5,994 -9.47 0.0022
2021-02-11 2020-12-31 13F BEIGENE ADR 07725L102 23,237 57 5,994 2,164.7142
2020-11-12 2020-09-30 13F BEIGENE ADR 07725L102 23,180 807 3.61 6,621 57.01 0.0028
2020-08-13 2020-06-30 13F BEIGENE ADR 07725L102 22,373 7,347 48.90 4,217 127.58 0.0019
2020-05-14 2020-03-31 13F BEIGENE ADR 07725L102 15,026 12,577 513.56 1,853 356.40 0.0010
2020-02-14 2019-12-31 13F BEIGENE ADR 07725L102 2,449 -128 -4.97 406 28.48 0.0001
2019-11-12 2019-09-30 13F BEIGENE ADR 07725L102 2,577 2,577 316 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.